Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Genistein (synthetic)

Tyrosine kinase inhibitor
ALX-350-006-M010 10 mg 45.00 USD
ALX-350-006-M025 25 mg 75.00 USD
ALX-350-006-M050 50 mg 142.00 USD
ALX-350-006-M100 100 mg 230.00 USD
ALX-350-006-G001 1 g 767.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-EI147

Tyrosine protein kinase inhibitor. Inhibits phosphorylation of EGFR kinase. Inhibits tumor cell proliferation and induces tumor cell differentiation. Inhibits topoisomerase II activity in vivo. Produces cell cycle arrest and apoptosis. Potent inhibitor of α-glucosidase, IC50 = 50nM.Direct inhibitor of insulin-induced glucose uptake in adipocytes (IC50=20µM).

Product Details

Alternative Name:4',5,7-Trihydroxyisoflavone
MI:14: 4391
Purity:≥98% (HPLC)
Appearance:Creamy off-white solid.
Solubility:Soluble in DMSO (30mg/ml), 100% ethanol (4mg/ml) or dilute aqueous base; insoluble in water.
Shipping:Ambient Temperature
Long Term Storage:-20°C
Handling:Protect from light.
Technical Info/Product Notes:Replacement for ADI-HPK-103
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Genistein Stimulation of White Adipose Tissue Thermogenesis Is Partially Dependent on GPR30 in Mice: S. Vasquez-Reyes, et al.; Mol. Nutr. Food Res. 66, e2100838 (2022), Abstract;
Effects of Ipriflavone-Loaded Mesoporous Nanospheres on theDifferentiation of Endothelial Progenitor Cells and TheirModulation by Macrophages: L. Casarrubios, et al.; Nanomaterials 11, 1102 (2021), Abstract;
GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment: H.G. Chang, et al.; Cells 10, 2811 (2021), Application(s): U343 cells treatment, Abstract; Full Text
Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation: A. Breit, et al.; Mol. Endocrinol. 29, 445 (2015), Application(s): ELISA, Abstract; Full Text
Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations: A. Dewell, et al.; J. Clin. Endocrinol. Metab. 91, 772 (2006), Review, Abstract;
Phytoestrogens and lipoproteins in women: C.N. Bairey Merz, et al.; J. Clin. Endocrinol. Metab. 91, 2209 (2006), Abstract;
The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy: F.H. Sarkar, et al.; Mini Rev. Med. Chem. 6, 401 (2006), Review, Abstract;
Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones: Y. Huang, et al.; J. Clin. Endocrinol. Metab. 90, 3956 (2005), Abstract;
Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes: M. Bazuine, et al.; BBRC 325, 511 (2005), Abstract;
Genistein affects testosterone secretion by Leydig cells in roosters (Gallus gallus domesticus): M. Opalka, et al.; Reprod. Biol. 4, 185 (2004), Abstract;
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy: N. Dijsselbloem, et al.; Biochem. Pharmacol. 68, 1171 (2004), Review, Abstract;
Mechanisms of cancer chemoprevention by soy isoflavone genistein: F.H. Sarkar & Y. Li; Cancer Metastasis Rev. 21, 265 (2002), Abstract;
Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor: D.S. Lee & S.H. Lee; FEBS Lett. 501, 84 (2001), Abstract;
The role of tyrosine phosphorylation in signal transduction through surface Ig in human B cells. Inhibition of tyrosine phosphorylation prevents intracellular calcium release: P.J. Lane et al.; J. Immunol. 146, 715 (1991), Abstract;
Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase: J.M. Trevillyan et al.; J. Immunol. 145, 3223 (1990), Abstract;
Effect of genistein, a tyrosine kinase inhibitor, on U46619-induced phosphoinositide phosphorylation in human platelets: D.C. Gaudette & J. B. Holub; Biochem. Biophys. Res. Commun. 170, 238 (1990), Abstract;
Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets: H. Salari, et al.; FEBS Lett. 263, 104 (1990), Abstract;
Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity: C. Linassier et al.; Biochem. Pharmacol. 39, 187 (1990), Abstract;
Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine: A. Dhar et al.; Mol. Pharmacol. 37, 519 (1990), Abstract;
T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation: T. Mustelin et al.; Science 247, 1584 (1990), Abstract;
Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells: N.M. Dean et al.; Biochem. Biophys. Res. Commun. 165, 795 (1989), Abstract;
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II: J. Markovits et al.; Cancer Res. 49, 5111 (1989), Abstract; Full Text
Genistein, a specific inhibitor of tyrosine-specific protein kinases: T. Akiyama, et al.; J. Biol. Chem. 262, 5592 (1987), Abstract; Full Text

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces